Levels of neutralizing antibodies in vaccinated individuals is a strong indicator of COVID-19 vaccine success- and this knowledge could be used to jump-start vaccine approvals and mass administration – even before large Phase 3 clinical trials are completed, suggests a new study by the University of Oxford Vaccine Group, Public Health England, and AstraZeneca.  Knowledge […] Continue reading ->
After months with virtually no therapeutic options for people with severe COVID-19, the World Health Organization (WHO) recommended the use of a class of medicines called interleukin-6 antagonists on Tuesday. The medicines, tocilizumab and sarilumab, reduced the risk of death and ventilation when combined with corticosteroids, according to a study published the same day in […] Continue reading ->
As many high-income countries are relaxing restrictions for the summer months, low- and middle-income countries (LMICs) are witnessing rises in cases, deaths, and overwhelmed hospitals.  Countries in Europe and the United States are increasingly allowing in travellers, ending mask mandates, and allowing large gatherings including football matches and concerts.  At the same time, the third […] Continue reading ->
Despite the emergence of new WHO concerns over quality control at Sputnik V’s domestic production facilities, the Russian Direct Investment Fund (RDIF) is pushing ahead with a massive international “open-license” manufacturing effort for its Sputnik V vaccine – which breaks the traditional model of vaccine production and leverages existing capacity in poorer countries, desperate for […] Continue reading ->
The Biden administration has been asked to clarify that sanctions against Cuba would not extend to collaborations in the development, manufacturing, distribution and sale of COVID-19 vaccines that the island nation is in the process of developing. A memorandum, sent by Knowledge Ecology International (KEI) on 28 June to the White House, asks the US […] Continue reading ->
African Union and WHO/African Region officials on Thursday sharply criticized the European Union decision to not grant the Indian version of AstraZeneca’s “Covishield” vaccine, distributed by the global COVAX facility, recognition in the new EU “Digital Green Pass programme” – amidst a growing chorus of global protests over the double standard. In a related statement, […] Continue reading ->